Pages not connected to items

Jump to navigation Jump to search

This page lists pages with no connected data item (in namespaces that support connected items). The list is sorted by descending page ID, so that newer pages are listed first.

 

Showing below up to 50 results in range #5,601 to #5,650.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Yu J, et al, JAMA oncology (2020), cited as Ref 2 in DOI:10.1016/j.adro.2020.04.015 (Q10764)
  2. Liang W, et al, The Lancet Oncology (2020), cited as Ref 1 in DOI:10.1016/j.adro.2020.04.015 (Q10763)
  3. Dubé M, et al, J Virol (2018), cited as Ref 69 in DOI: 10.1186/s13054-020-02882-x
  4. References (from DOI: 10.1186/s13054-020-02882-x) (Q10762)
  5. Competing interests (from DOI: 10.1186/s13054-020-02882-x) (Q10761)
  6. Consent for publication (from DOI: 10.1186/s13054-020-02882-x) (Q10760)
  7. Ethics approval and consent to participate (from DOI: 10.1186/s13054-020-02882-x) (Q10759)
  8. Availability of data and materials (from DOI: 10.1186/s13054-020-02882-x) (Q10758)
  9. Funding (from DOI: 10.1186/s13054-020-02882-x) (Q10757)
  10. Authors' contributions (from DOI: 10.1186/s13054-020-02882-x) (Q10756)
  11. Section 5: Conclusions (from DOI: 10.1186/s13054-020-02882-x) (Q10755)
  12. Section 4: COVID-19: ICU delirium management:potential problems and solutions (from DOI: 10.1186/s13054-020-02882-x) (Q10754)
  13. Section 3: COVID-19: Neuro-invasive potential of SARS-nCoV-2 as cause of delirium (from DOI: 10.1186/s13054-020-02882-x) (Q10753)
  14. Section 2: COVID-19: Potential factors contributing to ICU delirium (from DOI: 10.1186/s13054-020-02882-x) (Q10752)
  15. Section 1: Introduction (from DOI: 10.1186/s13054-020-02882-x) (Q10751)
  16. References (from DOI: 10.1183/13993003.01023-2020) (Q10750)
  17. Section 6: Potential Clinical Implications (from DOI: 10.1183/13993003.01023-2020) (Q10749)
  18. Section 5: Sleep and SARS-Cov 2 infection (from DOI: 10.1183/13993003.01023-2020) (Q10748)
  19. Section 4: Putative role of circadian clocks in the pathophysiology of SARS-CoV-2 infection (from DOI: 10.1183/13993003.01023-2020) (Q10747)
  20. Section 3: Role of ACE2 in SARS-CoV-2 infection (from DOI: 10.1183/13993003.01023-2020) (Q10746)
  21. Section 2: Viral infection pathophysiology and role of the circadian clock system (from DOI: 10.1183/13993003.01023-2020) (Q10745)
  22. Section 1: Introduction (from DOI: 10.1183/13993003.01023-2020) (Q10744)
  23. References (from DOI: 10.1007/s11886-020-01292-3) (Q10743)
  24. Conflict of Interest (from DOI: 10.1007/s11886-020-01292-3) (Q10742)
  25. Section 8: Conclusion (from DOI: 10.1007/s11886-020-01292-3) (Q10741)
  26. Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740)
  27. Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3) (Q10739)
  28. Section 5: Immune Responses to SARS-CoV-2 Infection and the Heart (from DOI: 10.1007/s11886-020-01292-3) (Q10738)
  29. Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10737)
  30. Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3) (Q10736)
  31. Section 2: Biology of SARS-CoV-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10735)
  32. Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3) (Q10734)
  33. Holshue ML, et al, N Engl J Med (2020) cited as Ref 8 in DOI: 10.1186/s13613-020-00653-z (Q10733)
  34. Yu P, et al, J Infect Dis (2020) cited as Ref 7 in DOI: 10.1186/s13613-020-00653-z (Q10732)
  35. Chan JF, et al, Lancet (2020) cited as Ref 6 in DOI: 10.1186/s13613-020-00653-z (Q10731)
  36. Li Q, et al, N Engl J Med (2020) cited as Ref 5 in DOI: 10.1186/s13613-020-00653-z (Q10730)
  37. Wang D, et al, JAMA (2020) cited as Ref 4 in DOI: 10.1186/s13613-020-00653-z (Q10729)
  38. Chen N, et al, Lancet (2020) cited as Ref 3 in DOI: 10.1186/s13613-020-00653-z (Q10728)
  39. Huang C, et al, Lancet (2020) cited as Ref 2 in DOI: 10.1186/s13613-020-00653-z (Q10727)
  40. Zhou P, et al, Nature (2020) cited as Ref 1 in DOI: 10.1186/s13613-020-00653-z (Q10726)
  41. References (from DOI: 10.1016/j.jcv.2020.104372) (Q10725)
  42. Declaration of Competing Interest (from DOI: 10.1016/j.jcv.2020.104372) (Q10724)
  43. Funding (from DOI: 10.1016/j.jcv.2020.104372) (Q10723)
  44. Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372) (Q10722)
  45. Section 2.3: Congenital and perinatal infections with SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) (Q10721)
  46. Section 2.2: Congenital and perinatal infections with coronaviruses other than SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) (Q10720)
  47. Section 2.1: Lessons from animal models (from DOI: 10.1016/j.jcv.2020.104372) (Q10719)
  48. Section 2: Is SARS-CoV-2 a congenital or perinatally-acquired pathogen for the neonate? (from DOI: 10.1016/j.jcv.2020.104372) (Q10718)
  49. Section 1: Introduction (from DOI: 10.1016/j.jcv.2020.104372) (Q10717)
  50. Kotfis K, et al, Anaesthesiol Intensive Ther (2018), cited as Ref 85 in DOI: 10.1186/s13054-020-02882-x (Q10716)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:UnconnectedPages"